Josep Nomdedéu

13PUBLICATIONS
73CO-AUTHORS
Medical mycologyGene expression (incl. microarray and other genome-wide approaches)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Nov 02, 2026
Measurable Residual Disease in IDH-Mutated AML: Identifying a Clinically Relevant Threshold for IDH Mutation Monitoring.

|Oct 14, 2026
Rapid molecular screening of adult AML: Experience from the Spanish CETLAM cooperative group.

|Aug 28, 2025
Telomere attrition becomes an instrument for clonal selection in aging hematopoiesis and leukemogenesis.

Matthew A McLoughlin, Sruthi Cheloor Kovilakam, William G Dunn

|Jan 11, 2025
Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group.

Guadalupe Oñate, Ana Garrido, Montserrat Arnan

|May 05, 2023
Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort.

Guadalupe Oñate, Marta Pratcorona, Ana Garrido

|Sep 01, 2021
Engraftment characterization of risk-stratified AML in NSGS mice.

Rafael Díaz de la Guardia, Talía Velasco-Hernandez, Francisco Gutiérrez-Agüera

Pageof 3

Frequent Collaborators

4 joint publications

Jorge Sierra

4 joint publications

Mar Tormo

4 joint publications

Guadalupe Oñate

3 joint publications

Antònia Sampol